In addition to abundant infiltrated lymphocytes, immunotherapy induced high levels of inhibitory components in post-treatment tissue samples, especially the FOXP3<sup>+</sup> regulatory T cells in tumor and PD-L1 expression in the lymph node. The gene discussed is CD274; the disease is neoplasm.